Abstract
Objective
The objective of the study is to analyze the influencing factors on the results of thyroid fine-needle aspiration biopsy (FNAB).
Method
A total of 339 patients who underwent FNAB in our hospital from December 2018 to July 2021 were retrospectively selected. The patients were chosen according to the gender ratio, age, and thyroid ultrasound characteristics and were divided into three groups: (1) a 22G needle vacuum aspiration group (Group 1, n = 85), (2) a 22G biopsy needle non-vacuum aspiration group (Group 2, n = 50), and (3) a 25G biopsy needle non-vacuum aspiration group (Group 3, n = 204). Patients in these groups were evaluated for determining the FNAB dissatisfaction rate of pathological samples. A bivariate regression analysis of independent risk factors related to the unsatisfactory pathological diagnosis of samples was performed.
Results
The specimen dissatisfaction rates of the three groups were 22/85 (25.9%), 15/50 (30%), and 18/186 (9.7%), respectively. The overall sample dissatisfaction rate was 55/339 (16.2%), and the sample satisfaction rate of Group 3 was higher than that of Groups 1 and 2 (P < 0.05). Logistic bivariate regression analysis showed that the age of the patients and the capillary sampling needles and aspiration methods were two independent risk factors for determining the dissatisfaction rate of FNAB pathological samples.
Conclusion
A 25G capillary sampling aspiration biopsy needle was selected to perform FNAB in thyroid nodules without vacuum aspiration, which could effectively improve the accuracy of FNAB results with a high specimen satisfaction rate.
Keywords: thyroid nodule, biopsy, needle, capillary, ultrasonography, cytology
Introduction
Thyroid nodules are one of the most common diseases encountered by the surgeons of the endocrinology and general surgery departments, of which malignant lesions account for a small proportion [1–3]. A large amount of data in evidence-based medicine have shown that fine-needle aspiration biopsy (FNAB) is a safe and minimally invasive diagnostic technique and is considered to be the current gold standard for distinguishing benign and malignant thyroid nodules [4–6]. FNAB can improve the accuracy of a preoperative diagnosis of thyroid nodules by up to 80%–90% [1], but it still cannot make a clear diagnosis in certain patients. Pathologists were unable to make a clinical diagnosis based on these samples due to an inadequate number of cells or difficulty in identifying cells in certain samples during the process of FNAB sampling. In this study, unsatisfactory FNAB samples by cytological diagnosis were selected to analyze the influencing factors on FNAB results of the thyroid and to improve the success rate of thyroid capillary sampling, thus providing favorable evidence for pathological diagnosis of thyroid FNAB.
Materials and methods
Subjects
This study was a retrospective analysis of 339 patients (79 male and 260 female) who underwent FNAB at the Aviation General Hospital in Beijing, China, from December 2018 to July 2021, with an average age of 47.38 ± 13.48 years. There were 55 cases of unsatisfactory pathologic results to analyze the influencing factors on FNAB results of the thyroid.
Methods
After collecting the thyroid ultrasound characteristics of the patients, including nodule size, blood flow, type, and boundary, as well as needles and aspiration methods used for thyroid FNAB, all patients were divided into three groups according to the different types of needles and aspiration methods used in FNAB. Group 1: a 22G biopsy needle (outside diameter 0.7 mm) vacuum aspiration group (n = 85); Group 2: a 22G needle (outside diameter 0.7 mm) capillary sampling aspiration group (n = 50); Group 3: a 25G biopsy needle (outside diameter 0.5 mm) capillary sampling aspiration group (n = 204). The three groups were compared for determining the satisfaction rate of thyroid cell samples. All the enrolled patients were evaluated for thyroid nodule risk by thyroid specialists who would determine whether to perform FNAB according to the inclusion criteria (1), as well as thyroid ultrasound characteristics and clinical conditions. All FNAB patients signed informed consent forms. This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Aviation General Hospital.
Inclusion criteria for FNAB
Before FNAB, all patients were graded for thyroid nodules by the attending physician or a higher-level physician in the ultrasound department. One or more of the following malignant signs in the thyroid ultrasound examination indicated an increased risk of malignancy: solid, low echo or very low echo, microcalcification, blurred boundary/differential lobe, aspect ratio >1A. The decision of whether to perform FNAB was made based on the features of thyroid nodule ultrasound, medical history, and family history.
FNAB procedure
Place the patient in the supine position and use a neck pillow to fully expose the patient's neck. To ensure strict aseptic operation for FNAB, disinfect the skin of the neck with iodophor and spread a sterile towel. Insert the needle from the side of the ultrasonic probe under the guidance of ultrasound and direct the whole needle tip to reach the thyroid nodule during the operation, ensuring that the capillary sampling site is at the target nodule. Use a 22G injection needle, a 22G biopsy needle, or a 25G biopsy needle as the capillary sampling needle. Use the vacuum aspiration method when aspirating cells with a 22G injection needle, and use the capillary siphoning method when aspirating cells with a 22G biopsy needle or a 25G biopsy needle. Prepare 1–2 smears using the cells obtained from each biopsy, perform routine biopsy three times at each nodule, and obtain 3–6 samples from each nodule. The samples were considered unsatisfactory if all samples from the same nodule did not meet the diagnostic conditions [7]. All FNAB procedures were performed by a pathologist with more than 10 years of experience under ultrasound guidance.
Specimen determination
All smear samples were completed by two pathologists with titles of attending physician or higher, and the pathological diagnosis was made based on the “Bethesda system for reporting thyroid cytopathology” (TBSRTC), 1st edition [8]. See the six diagnostic classifications of TBSRTC in Table 1. TBSRTC Class I was the diagnostic unsatisfactory group, while the other five were the satisfactory groups.
Table 1.
The Bethesda system for reporting thyroid cytopathology (TBSRTC).
| Category | Clinical significance | Risk of malignancy (%) |
|---|---|---|
| Category I, TBSRTC | Non-diagnosable or unsatisfactory specimens | 1–4 |
| Category II, TBSRTC | Benign follicular nodules | 0–3 |
| Category III, TBSRTC | Atypical cells of uncertain significance | 5–15 |
| Category IV, TBSRTC | Follicular tumor or suspected follicular tumor | 15–30 |
| Category V, TBSRTC | Suspected malignant tumor | 60–75 |
| Category VI, TBSRTC | Malignant tumor | 97–99 |
Statistical method
SPSS 20.0 software was used for statistical processing, and the measurement data were expressed by mean ± standard deviation (x ± s). After a normality test and a test for determining the homogeneity of variances, an independent sample analysis of variance was made to compare the measurement data of normal distribution and homogeneity of variance between the three groups. The enumeration data were expressed by the number of cases and percentage, and the χ2 test was used to compare the enumeration data among the three groups. The difference was considered statistically significant if P < 0.05. Logistic bivariate regression analysis was used to analyze the risk factors, with α = 0.05.
Results
Demographics and baseline data
A comparison of baseline clinical data among the three groups indicated that there were no statistically significant differences among the three groups in terms of gender ratio, age, and thyroid function (P > 0.05), as shown in Table 2. According to the ultrasonic examination features, there were no significant differences among the three groups in terms of nodule blood flow, calcification, and solid-cystic type. The diameter of the thyroid nodules in Group 1 was slightly larger than those in Groups 2 and 3. There were more nodules with an aspect ratio greater than 1 in Group 2.
Table 2.
Comparison between the two groups in terms of general clinical conditions and thyroid ultrasound features (x ± s).
| Group | Group 1 | Group 2 | Group 3 | P value |
|---|---|---|---|---|
| n (M/F) | 21/64 | 10/40 | 48/156 | 0.817 |
| Age (Years) | 48.35 ± 13.48 | 50.80 ± 13.97 | 46.15 ± 13.27 | 0.067 |
| TSH (uiu/ml) | 1.94 ± 1.22 | 1.93 ± 1.39 | 2.08 ± 1.18 | 0.628 |
| Nodule size (cm) | 1.32 ± 0.87 | 1.01 ± 0.96 | 1.07 ± 0.79 | 0.049 |
| Nodule blood flow (no/little/abundant) | 18/43/24 | 18/23/9 | 63/106/35 | 0.139 |
| Nodule type (solid/solid-cystic) | 72/13 | 44/6 | 188/16 | 0.15 |
| Aspect ratio greater than 1 (case) | 18/85 | 22/50 | 73/204 | 0.012 |
| Calcification (case) (no/tiny/thick) | 42/26/17 | 19/22/9 | 94/84/26 | 0.253 |
Group 1: Vacuum aspiration with 22G injection needle; Group 2: Capillary siphoning with 22G biopsy needle; Group 3: Capillary siphoning with 25G biopsy needle.
Analysis of the capillary sampling satisfaction rate of the three groups
The dissatisfaction rates of capillary sampling results in the three groups were 22/85 (25.88%), 15/50 (30%), and 18/204 (8.82%), respectively, indicating significant differences among the three groups (P < 0.001). The capillary sampling dissatisfaction rate of patients in Group 3 was significantly lower than that of those in the other two groups (see Table 3). There were no significant differences between Groups 1 and 2.
Table 3.
Comparison between different capillary sampling needles and aspiration methods in terms of cytopathological satisfaction of thyroid fine-needle aspiration biopsy (FNAB).
| Pathological results | Group 1 | Group 2 | Group 3 | Chi-square value | P value |
|---|---|---|---|---|---|
| Satisfactory puncture results | 63 | 35 | 186 | 21.04 | <0.001 |
| Unsatisfactory puncture results | 22 | 15 | 18 |
Group 1: Vacuum aspiration with 22G injection needle; Group 2: Capillary sampling with 22G biopsy needle; Group 3: Capillary sampling with 25G biopsy needle.
Logistic regression analysis of independent risk factors for unsatisfactory capillary sampling results
Risk factor analysis: Logistic regression analysis was conducted for age, gender, nodule size, nodule location, nodule blood flow, nodular aspect ratio, nodule morphology, nodule border, nodule calcification, TSH level, and capillary sampling needles and aspiration methods. The statistical results showed that age and capillary sampling needles and aspiration methods were the independent risk factors for thyroid capillary sampling pathological results, with the odds ratio (OR) values being 0.95 and 2.03, respectively (see Table 4).
Table 4.
Logistic regression analysis of independent risk factors for unsatisfactory thyroid FNAB pathological results.
| Index | B | SE(b) | Wald–χ | P | OR | 95% CI |
|---|---|---|---|---|---|---|
| Age | −0.55 | 0.013 | 16.64 | <0.001 | 0.95 | 0.92–0.97 |
| Gender | 0.431 | 0.405 | 1.132 | .287 | 1.54 | 0.70–3.41 |
| Nodule size | −0.086 | 0.225 | 0.144 | 0.704 | 0.918 | 0.590–1.428 |
| Nodule location | 0.373 | 0.350 | 1.137 | 0.286 | 1.452 | 0.731–2.884 |
| Nodule blood flow | 0.080 | 0.274 | 0.086 | 0.769 | 1.084 | 0.634–1.853 |
| Nodular aspect ratio | 0.086 | 0.406 | 0.045 | 0.833 | 1.090 | 0.492–2.415 |
| Nodule morphology | 0.667 | 0.451 | 2.187 | 0.139 | 1.948 | 0.805–4.713 |
| Nodule border | −0.663 | 0.401 | 2.731 | 0.098 | 0.515 | 0.235–1.131 |
| Nodule calcification | −0.245 | 0.264 | 0.861 | 0.354 | 0.783 | 0.466–1.314 |
| TSH level | −0.041 | 0.149 | 0.077 | 0.781 | 0.960 | 0.717–1.285 |
| Capillary sampling needles and aspiration methods | 0.699 | 0.196 | 12.74 | <0.001 | 2.03 | 1.37–2.99 |
OR, odds ratio.
Discussion
In the current TBSRTC system (2nd edition), guidelines for the management of patients with thyroid nodules, the introduction of molecular testing as an adjunct to cytopathologic examination, and the reclassification of the non-invasive follicular variant of papillary thyroid carcinoma as non-invasive follicular thyroid neoplasm with papillary-like nuclear features are all revised [9]. According to the current system of TBSRTC, thyroid nodules are classified into six diagnostic categories as follows: non-diagnostic (ND) or unsatisfactory (UNS); benign; atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS); follicular neoplasm (FN) or suspicious for a follicular neoplasm (SFN); suspicious for malignancy (SFM); and malignant. The risks of malignancy for the six categories are 5% to 10%, 0% to 3%, 6% to 18%, 10% to 40%, 45% to 60%, and 94% to 96%, respectively, which are different from TBSRTC, 1st edition (10).
The detectable rate of thyroid nodules in the population is increasing year by year, with continuous improvement in people's health awareness and ultrasound technology, which is 20%–70% in different populations [11–13]. Malignant tumors account for 5%–15% of thyroid nodules [1, 3]. Thyroid tumors are prone to secondary changes, such as calcification, fibrosis, edema, and hemorrhage [6], which provide a basis for distinguishing benign and malignant nodules. Characterized by simplicity, economy, and non-invasiveness, high-resolution ultrasound technology is the preferred examination method for the clinical screening of both benign and malignant thyroid nodules [1, 6]. However, there are obvious overlap manifestations in the ultrasound characteristics of benign and malignant thyroid tumors, due to multiple pathological types and the heterogeneity of the biological characteristics of thyroid cancer. In addition, ultrasound diagnosis depends on the experience of sonologists, the resolution of ultrasound equipment, and other factors, and the coincidence rate of thyroid ultrasound and pathology is 60%–80% [6]. Therefore, in both domestic and foreign guidelines, FNAB is recommended for nodules with malignant signs in thyroid ultrasound imaging. FNAB can improve the preoperative diagnosis accuracy of thyroid nodules by up to 80%–90% [1, 7] and is recognized as the gold standard for determining benign and malignant thyroid nodules.
Individual differences in thyroid nodules and the complexity of clinical conditions can contribute to the failure to make a diagnosis based on the cytopathological results of thyroid FNAB in certain patients, affecting one’s judgment on the nature of thyroid nodules. Previous studies have shown that the factors affecting the unsatisfactory pathological diagnosis of FNAB may include the nature of nodules (such as cystic nodules), the size of the thyroid capillary sampling needle, and the method of cell aspiration [14–16]. After a series of improvements in thyroid capillary sampling needles and aspiration methods, it was found that fine needles are recommended for thyroid capillary sampling for their safety and favorable effect, and 21–27G capillary sampling needles are preferred over others [17]. However, there is still a controversy surrounding which type of capillary sampling needle has the best effect. This is a retrospective study, and the results of logistic bivariate regression analysis suggest that the diameter of the needle and the aspiration method used for thyroid capillary sampling, as well as the age of the patient, are independent risk factors for unsatisfactory pathological diagnosis of FNAB, which is consistent with those of previous studies [14]. The risk coefficients of the two independent risk factors in this study were 2.01 and 0.95, respectively, suggesting that different needle diameters and aspiration methods had a significant influence on the results. According to the Birmingham Wire Gauge, the larger the size of the capillary sampling needle, the smaller the aperture will be. The outer diameters of the 25G biopsy needles and the 22G needles used in this study were 5 and 7 mm, respectively. Through an analysis and comparison of the influences of different needle diameters and aspiration methods on the pathological results, it was found in this study that a 25G needle without vacuum aspiration could increase the FNAB diagnosis rate, which was consistent with previous research results [18], while a 27G capillary sampling needle had also been shown to be better in some studies [19], indicating that the effect of fine needles is better than that of thicker needles. Accumulated studies of the thyroid fine-needle aspiration technique have reported that the sufficiency for diagnosis could be increased by selecting smaller needles [20, 21]. Very recently, Shumrick et al. [22] carried out a study to compare the diagnostic capability between 25G and 27G needles for ultrasound-guided fine-needle biopsy of thyroid nodules, and they concluded that a 27G needle for FNBs yields better diagnostic information than 25G needles. Sengul et al. [23–27] have recommended that Thy MIFNA with a 27G fine-needle could be applied in the ultrasonography-guided FNA procedure due to low rates of Category I (TBSRTC, 1st and 2nd editions.) and low severity of pain. Clinically, the special aspiration biopsy needles for thyroid biopsy are used based on the capillary siphoning principle rather than vacuum aspiration, and capillary siphoning can successfully extract cells, which can reduce bleeding while providing convenience. Gill et al. [14] showed that the non-vacuum aspiration method could significantly reduce the dissatisfaction rate of FNAB pathological diagnosis. By comparing the influence of a 22G needle with different aspiration methods on pathological diagnosis, this study showed that there was no significant difference in the dissatisfaction rate of extracted cells with different aspiration methods, which was inconsistent with the research results of Gill et al. [28] but consistent with the results of previous meta-analysis. The study revealed that compared with a 22G needle, a 25G needle could significantly reduce medical expenses and save medical costs from the perspective of economic benefit and cost ratio, and the effect was similar to that of the use of a 22G biopsy needle. However, there were few cases in the 22G capillary sampling needle group in this study, and there was a lack of comparison with vacuum aspiration because it was not used in the 25G capillary sampling biopsy needle group. Therefore, in order to further prove the causal relationship between the vacuum aspiration and the satisfaction rate of the pathological results of thyroid capillary sampling biopsy, a randomized controlled clinical research study with a large sample size is required for verification.
In conclusion, despite the limited sample size and possible deviations in the sample selection and statistical process, this study suggests that a 25G aspiration biopsy needle without vacuum aspiration could significantly improve the pathological diagnosis rate of FNAB, and that the use or non-use of vacuum aspiration in the 22G capillary sampling needle group had little influence on cytodiagnosis.
Footnotes
The aspect ratio of thyroid B-mode ultrasound is greater than 1. The concept of aspect ratio refers to the ratio of the anterior to posterior diameter of a lesion or nodule to the left and right diameter on the transverse section of the thyroid gland. The longitudinal refers to the anterior to posterior diameter, and the transverse refers to the left and right diameter. If the anterior and posterior diameter of the nodule is greater than the left and right diameter, and the longitudinal ratio is greater than 1, the nodule tends to be upright on ultrasound images, and such nodule is more likely to be malignant.
Funding
This study was supported by the Aviation General Hospital Science Foundation of China (No. YJ2020003).
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, Further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving human participants were reviewed and approved by the Ethics Committee of Aviation General Hospital. The patients/participants provided their written informed consent to participate in this study.
Author contributions
Conception and design of the research was done by CW, ZW; acquisition of data was done by YZ, YR, and YL; analysis and interpretation of the data was done by CW; statistical analysis was performed by CW; financing was arranged by CW; writing of the manuscript was done by CW; critical revision of the manuscript for intellectual content was done by ZJ and ZW. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- 1.Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. (2016) 26(1):1–133. 10.1089/thy.2015.0020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: Revised Korean society of thyroid radiology consensus statement and recommendations. Korean J Radiol. (2016) 17(3):370–95. 10.3348/kjr.2016.17.3.370 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary thyroid nodule evaluation and management. J Clin Endocrinol Metab. (2020) 105(9):2869–83. 10.1210/clinem/dgaa322 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Paschke R, Cantara S, Crescenzi A, Jarzab B, Musholt TJ, Sobrinho Simoes M. European Thyroid Association guidelines regarding thyroid nodule molecular fine-needle aspiration cytology diagnostics. Eur Thyroid J. (2017) 6(3):115–29. 10.1159/000468519 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hong MJ, Na DG, Kim SJ, Kim DS. Role of core needle biopsy as a first-line diagnostic tool for thyroid nodules: A retrospective cohort study. Ultrasonography. (2018) 37(3):244–53. 10.14366/usg.17041 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Surgeons Branch of Chinese Medical Association, Committee of Thyroid Surgeons. Expert consensus and guidelines for ultrasound-guided fine needle needle biopsy of thyroid nodules (2018 edition). Zhongguo Shiyong Waike Zazhi. (2018) 38(3):241–4. CNKI:SUN:ZGWK.0.2018-03-001 [Google Scholar]
- 7.National Health Commission of the People's Republic of China. Guidelines for the diagnosis and treatment of thyroid cancer (2018 edition). Chin Arch Gen Surg (Electronic Edition). (2019) 13(1):1–15. 10.3877/cma.j.issn.1674-0793.2019.01.001 [DOI] [Google Scholar]
- 8.Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. (2009) 19(11):1159–65. 10.1089/thy.2009.0274 [DOI] [PubMed] [Google Scholar]
- 9.Zhu Y, Song Y, Xu G, Fan Z, Ren W. The Bethesda system for reporting thyroid cytopathology (TBSRTC): A report of 2,781 cases in a Chinese population. Chin J Cancer Res. (2020) 32(2):140–8. 10.21147/j.issn.1000-9604.2020.02.02 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sheng D, Yu X, Li H, Zhang M, Chen J. BRAF V600e mutation and the Bethesda system for reporting thyroid cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules. Medicine. (2021) 100(37):e27167. 10.1097/MD.0000000000027167 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Moon JH, Hyun MK, Lee JY, Shim JI, Kim TH, Choi HS, et al. Prevalence of thyroid nodules and their associated clinical parameters: A large-scale, multicenter-based health checkup study. Korean J Intern Med. (2018) 33(4):753–62. 10.3904/kjim.2015.273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ospina NS, Papaleontiou M. Thyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologists. Endocr Pract. (2021) 27(3):261–8. 10.1016/j.eprac.2021.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cahoon EK, Nadyrov EA, Polyanskaya ON, Yauseyenka VV, Veyalkin IV, Yeudachkova TI, et al. Risk of thyroid nodules in residents of Belarus exposed to chernobyl fallout as children and adolescents. J Clin Endocrinol Metab. (2017) 102(7):2207–17. 10.1210/jc.2016-3842 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Gill AS, Amdur R, Joshi AS. Importance of FNA technique for decreasing non-diagnostic rates in thyroid nodules. Head Neck Pathol. (2018) 12(2):160–5. 10.1007/s12105-017-0844-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Isaac A, Jeffery CC, Seikaly H, Al-Marzouki H, Harris JR, O'Connell DA. Predictors of non-diagnostic cytology in surgeon-performed ultrasound guided fine needle aspiration of thyroid nodules. J Otolaryngol Head Neck Surg. (2014) 43(1):48. 10.1186/s40463-014-0048-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Leung VA, Kirpalani A, Mnatzakanian G, Colak E, Vlachou PA. Effect of a biopsy center on adequacy rates of thyroid nodule fine-needle aspiration. AJR Am J Roentgenol. (2017) 209(2):358–62. 10.2214/AJR.16.17157 [DOI] [PubMed] [Google Scholar]
- 17.Li CL, Zhou L, Sun H. Status and progress of fine needle aspiration biopsy for thyroid nodules in China. Chin J Plast Surg. (2020) 40(2):195–8. 10.19538/j.cjps.issn1005-2208.2020.02.13 [DOI] [Google Scholar]
- 18.Dong Y, Gao L, Sui Y, Mao M, Zhan W, Zhou J. Comparison of ultrasound-guided fine-needle cytology quality in thyroid nodules with 22-, 23-, and 25-gauge needles. Anal Cell Pathol. (2021) 2021:5544921. 10.1155/2021/5544921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Shumrick CM, Simmonds JC, Ogden LL, Snowden CA, Dhingra JK. A blinded randomized trial comparing 2 needle gauges for fine-biopsy needle of thyroid nodules. OTO Open. (2021) 5(2):2473974X211013732. 10.1177/2473974X211013732 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pitman MB, Abele J, Ali SZ, Duick D, Elsheikh TM, Jeffrey RB, et al. Techniques for thyroid FNA: A synopsis of the national cancer institute thyroid fine-NeedleAspiration state of the science conference. Diagn Cytopathol. (2008) 36(6):407–24. 10.1002/dc.20829 [DOI] [PubMed] [Google Scholar]
- 21.Haddadi-Nezhad S, Larijani B, Tavangar SM, Nouraei SM. Comparison of fine-needle-nonaspiration with fine-needle-aspiration technique in the cytologic studies of thyroid nodules. Endocr Pathol. (2003) 14 (4):369–73. 10.1385/EP:14:4:369 [DOI] [PubMed] [Google Scholar]
- 22.Shumrick CM, Simmonds JC, Ogden LL, Snowden CA, Dhingra JK. A blinded randomized trial comparing 2 needle gauges for fine-needle biopsy of thyroid nodules. OTO Open. (2021) 5(2):2473974X211013732. 10.1177/2473974X211013732 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Sengul D, Sengul I. Minimum minimorum: Thyroid minimally invasive FNA, less is more concept? Volens nolens? Rev Assoc Med Bras. (2022 Mar) 68(3):275–6. 10.1590/1806-9282.20211181 [DOI] [PubMed] [Google Scholar]
- 24.Sengul I, Sengul D, Veiga ECA. Revisiting optimal needle size for thyroid fine-needle aspiration cytology: Not much finer, less non-diagnostic? Rev Assoc Med Bras. (2021) 67(9):1213–4. 10.1590/1806-9282.20210671 [DOI] [PubMed] [Google Scholar]
- 25.Sengul I, Sengul D. Proposal of a novel terminology: Minimally invasive FNA and thyroid minimally invasive FNA; MIFNA and thyroid MIFNA. Ann Ital Chir. (2021) 92:330–1. PMID: [PubMed] [Google Scholar]
- 26.Sengul I, Sengul D. Delicate needle with the finest gauge for a butterfly gland, the thyroid: Is it worth mentioning? Sanamed. (2021) 16(2):173–4. 10.24125/sanamed.v16i2.515 [DOI] [Google Scholar]
- 27.Sengul I, Sengul D. Big gain, no pain: Thyroid minimally invasive FNA (thy MIFNA): Proposal of novelty in terminology. Rev Assoc Med Bras. (2021) 67(12):1749–50. 10.1590/1806-9282.20210922 [DOI] [PubMed] [Google Scholar]
- 28.Song H, Wei C, Li D, Hua K, Song J, Maskey N, et al. Comparison of fine needle aspiration and fine needle nonaspiration cytology of thyroid nodules: A meta-analysis. Biomed Res Int. (2015) 2015:796120. 10.1155/2015/796120 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material, Further inquiries can be directed to the corresponding author.